We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VHAI.WS.B
8801
DELISTED
Vocodia Holdings Corp. Series B Warrants
VHAI.WS.B
$595 ﹤0.01%
+35
New +$585
RDIB
8802
Reading International Class B
RDIB
$590 ﹤0.01%
44
-48
-52% -$685
EVOK
8803
DELISTED
Evoke Pharma
EVOK
$586 ﹤0.01%
92
SCNI
8804
Scinai Immunotherapeutics
SCNI
$1.41M
$586 ﹤0.01%
211
-1
-0.5% -$4
LGHLW
8805
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$584 ﹤0.01%
+83,420
New +$492
WDNA icon
8806
WisdomTree BioRevolution Fund
WDNA
$2.53M
$584 ﹤0.01%
37
-62
-63% -$994
SMAY icon
8807
FT Vest US Small Cap Moderate Buffer ETF May
SMAY
$110M
$583 ﹤0.01%
25
+20
+400% +$458
IPHA
8808
Innate Pharma
IPHA
$164M
$576 ﹤0.01%
297
+87
+41% +$219
TWOU
8809
DELISTED
2U Inc
TWOU
$575 ﹤0.01%
112
-2,637
-96% -$22.8K
UAMY icon
8810
United States Antimony
UAMY
$751M
$573 ﹤0.01%
+1,705
New +$475
JTAIZ
8811
DELISTED
Jet.AI Inc. Merger Consideration Warrants
JTAIZ
$572 ﹤0.01%
+1,348
New +$508
EWK icon
8812
iShares MSCI Belgium ETF
EWK
$164M
$571 ﹤0.01%
+31
New +$586
IBIB
8813
DELISTED
iShares iBonds Oct 2025 Term TIPS ETF
IBIB
$565 ﹤0.01%
+22
New +$561
SKYH.WS icon
8814
Sky Harbour Group Warrants
SKYH.WS
$17.1M
$565 ﹤0.01%
+456
New +$604
FIG
8815
DELISTED
Simplify Macro Strategy ETF
FIG
$564 ﹤0.01%
27
-467
-95% -$10.2K
VRPX
8816
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$562 ﹤0.01%
+43
New +$2.1K
PWUPU
8817
DELISTED
PowerUp Acquisition Corp. Unit
PWUPU
$561 ﹤0.01%
56
+27
+93% +$303
GTAC
8818
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$561 ﹤0.01%
50
AAME icon
8819
Atlantic American Corp
AAME
$31.4M
$559 ﹤0.01%
+331
New +$622
IRTR icon
8820
iShares LifePath Retirement ETF
IRTR
$57.7M
$556 ﹤0.01%
+20
New +$548
FMED icon
8821
Fidelity Disruptive Medicine ETF
FMED
$44.8M
$553 ﹤0.01%
+23
New +$555
PAYOW
8822
DELISTED
Payoneer Global Inc. Warrant
PAYOW
$553 ﹤0.01%
2,396
+1,046
+77% +$298
TCOA.U
8823
DELISTED
Zalatoris Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one redeemable public warrant
TCOA.U
$553 ﹤0.01%
50
GRDX
8824
GridAI Technologies Corp
GRDX
$20.4M
$552 ﹤0.01%
+150
New +$1.24K
RCFA.U
8825
DELISTED
Perception Capital Corp. IV Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
RCFA.U
$551 ﹤0.01%
50

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.